Ownership history in JOHNSON & JOHNSON · 18 quarters on record
This page tracks every 13F SEC filing in which JOHNSON & JOHNSON reported a position in VOR BIOPHARMA, INC. (VOR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 53,732 | — | 0% | 0.13% | $703K | $13.08 |
| 2025 Q3 | REDUCED | 53,732 | -1,020,926 | -95.0% | 0.52% | $2.6M | $48.72 |
| 2025 Q2 | UNCHANGED | 1,074,658 | — | 0% | 0.34% | $1.1M | $32.40 |
| 2025 Q1 | UNCHANGED | 1,074,658 | — | 0% | 0.23% | $771K | $14.36 |
As of 2025 Q4 — sorted by position size